Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Otolaryngol Head Neck Surg ; 133(1): 66-9, 2005 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-16025055

RESUMO

OBJECTIVE: To identify the incidence of parapharyngeal space (PPS) recurrences and how they impact survival in advanced-stage soft-palate carcinoma patients. STUDY DESIGN AND SETTING: One hundred thirty-seven patients' charts were reviewed from 1971 to 1996. Inclusion criteria were patients who received a per-oral resection, discontinuous neck dissection, and postoperative adjuvant radiation therapy; 15 patients met criteria for inclusion. The incidence of PPS recurrences, regional failure, and survival were endpoints that were analyzed. RESULTS: There were no local failures in our study. Regional failures excluding the PPS (levels I-V) were 27%, and 40% occurred within the PPS. Cervical adenopathy was associated with 83% of the PPS recurrences. Median survival for PPS recurrences was 26 months, compared with 67 months for levels I-V recurrences (n = ns). CONCLUSIONS: The incidence of PPS recurrences is substantial in advanced-stage soft-palate cancer. PPS recurrences negatively impact survival; without effective salvage techniques for these recurrences or effective adjuvant therapy, poor patient outcomes can be expected.


Assuntos
Carcinoma de Células Escamosas/epidemiologia , Carcinoma de Células Escamosas/patologia , Recidiva Local de Neoplasia/epidemiologia , Neoplasias Palatinas/patologia , Neoplasias Faríngeas/epidemiologia , Adulto , Idoso , Carcinoma de Células Escamosas/secundário , Feminino , Humanos , Incidência , Masculino , Pessoa de Meia-Idade , Estadiamento de Neoplasias , Procedimentos Cirúrgicos Otorrinolaringológicos , Palato Mole , Neoplasias Faríngeas/patologia , Neoplasias Faríngeas/secundário , Faringe , Radioterapia Adjuvante , Estudos Retrospectivos , Análise de Sobrevida
2.
Ann Surg Oncol ; 11(6): 573-80, 2004 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-15172932

RESUMO

BACKGROUND: Postmastectomy radiotherapy (PMRT) has proven benefits for certain patients with breast cancer; however, one of its complications is lymphedema. This study examines the incidence of and risk factors associated with lymphedema secondary to PMRT. METHODS: The charts of patients treated with mastectomy at Roswell Park Cancer Institute between January 1, 1995, and April 20, 2001, who received PMRT were reviewed. Univariate analysis of patient, disease, and treatment variables was conducted. Multivariate analysis was performed on variables found to be significant in univariate analysis. RESULTS: One hundred five patients received PMRT. The incidence of lymphedema was 27%. Patient age, body mass index, disease stage, positive lymph nodes, nodes resected, postoperative infection, duration of drainage, chemotherapy, and hormonal therapy were not associated with lymphedema. Total dose (P =.032), posterior axillary boost (P =.047), overlap technique (P =.037), radiotherapy before 1999 (P =.028), and radiotherapy at Roswell Park Cancer Institute (P =.028) were significantly associated with lymphedema. Increased lymphedema was noted with supraclavicular, internal mammary, mastectomy scar boost, and chest wall tangential photon beam radiation, but the associations were not statistically significant. CONCLUSIONS: The high incidence and debilitating effects of lymphedema must be weighed against the benefits of PMRT. Efforts to prevent lymphedema should be emphasized.


Assuntos
Neoplasias da Mama/radioterapia , Linfedema/epidemiologia , Neoplasias da Mama/cirurgia , Feminino , Humanos , Incidência , Linfedema/etiologia , Pessoa de Meia-Idade , Análise Multivariada , New York/epidemiologia , Radioterapia Adjuvante/efeitos adversos , Estudos Retrospectivos , Fatores de Risco
3.
Surg Oncol Clin N Am ; 13(1): 187-99, 2004 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-15062369

RESUMO

Treatment strategies that have the potential to improve functional organ preservation in patients who have head and neck cancer are emerging. Clinical research in this field, however, has been limited by the lack of standardized, objective criteria of organ function post treatment and by lack of prospective assessment of organ function in treatment trials [56]. Advances in surgical techniques, radiation techniques, radiation protectants, and combined-modality therapies are promising, but well-planned and executed clinical trials are necessary to determine how best to apply these techniques to patient care.


Assuntos
Neoplasias de Cabeça e Pescoço/cirurgia , Neoplasias de Células Escamosas/cirurgia , Deglutição , Neoplasias de Cabeça e Pescoço/fisiopatologia , Neoplasias de Cabeça e Pescoço/radioterapia , Humanos , Neoplasias de Células Escamosas/fisiopatologia , Neoplasias de Células Escamosas/radioterapia , Radioterapia/efeitos adversos , Glândulas Salivares/efeitos da radiação , Salivação , Qualidade da Voz , Xerostomia/etiologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...